Our Mission

Earlier today, Takeda announced a US only recall of Natpara, effective immediately. This recall is based on a discussion with FDA regarding a potential issue with the rubber septum in the Natpara cartridge. The concern is that with repeated punctures of the septum by the needles, it may be possible for small rubber fragments to detach into the cartridge. The attached press release contains additional information. {will include a link to the full release} Takeda will communicate directly with all healthcare professionals, patients and specialty pharmacies. Patients should contact their prescribing healthcare provider to discuss their individual treatment plan. The HypoPARAthyroidism Association appreciates how many of our members this may impact and we will continue to share any information with you as it is available.